tiprankstipranks
Alpha Cognition Inc (TSE:ACOG)
CNQX:ACOG
Holding TSE:ACOG?
Track your performance easily

Alpha Cognition Inc (ACOG) Stock Price & Analysis

18 Followers

ACOG Stock Chart & Stats


Financials

Annual

ACOG FAQ

What was Alpha Cognition Inc’s price range in the past 12 months?
Alpha Cognition Inc lowest stock price was C$7.25 and its highest was C$24.73 in the past 12 months.
    What is Alpha Cognition Inc’s market cap?
    Currently, no data Available
    When is Alpha Cognition Inc’s upcoming earnings report date?
    Alpha Cognition Inc’s upcoming earnings report date is Apr 24, 2025 which is in 122 days.
      How were Alpha Cognition Inc’s earnings last quarter?
      Alpha Cognition Inc released its earnings results on Nov 15, 2024. The company reported -C$0.436 earnings per share for the quarter, beating the consensus estimate of -C$1.362 by C$0.926.
        Is Alpha Cognition Inc overvalued?
        According to Wall Street analysts Alpha Cognition Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Alpha Cognition Inc pay dividends?
          Alpha Cognition Inc does not currently pay dividends.
          What is Alpha Cognition Inc’s EPS estimate?
          Alpha Cognition Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Alpha Cognition Inc have?
          Currently, no data Available
          What happened to Alpha Cognition Inc’s price movement after its last earnings report?
          Alpha Cognition Inc reported an EPS of -C$0.436 in its last earnings report, beating expectations of -C$1.362. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of Alpha Cognition Inc?
            Currently, no hedge funds are holding shares in TSE:ACOG
            ---

            Company Description

            Alpha Cognition Inc

            Alpha Cognition Inc is a clinical-stage biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases such as Alzheimer's Disease and Amyotrophic Lateral Sclerosis. ALPHA-1062 is a patented new chemical entity that has demonstrated safety and improved tolerability in human clinical trials. It is being developed as a new acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type, with minimal gastrointestinal side effects and novel routes of administration.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            BriaCell Therapeutics
            Edesa Biotech
            Resverlogix
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis